Urea cycle disorders
Also known as: urea cycle defects
Urea cycle disorders are inherited enzyme deficiencies that block the conversion of ammonia into urea, causing ammonia to accumulate in the blood. Hyperammonemia is the common feature, and it is neurotoxic.
The urea cycle disposes of the nitrogen released when amino acids are broken down. Free ammonia is toxic, so the liver converts it through a five-step pathway spanning the mitochondrion and cytosol into urea, which the kidneys excrete. The enzymes in sequence are carbamoyl phosphate synthetase I, ornithine transcarbamylase, argininosuccinate synthetase, argininosuccinate lyase, and arginase. A deficiency at any step backs the pathway up and raises blood ammonia.
Ornithine transcarbamylase (OTC) deficiency is the most common urea cycle disorder and the only one inherited in an X-linked recessive pattern; the rest are autosomal recessive. Its biochemical signature is distinctive: carbamoyl phosphate that cannot proceed through the cycle accumulates in the mitochondrion, spills into the cytosol, and is diverted into pyrimidine synthesis, producing elevated orotic acid in blood and urine along with hyperammonemia and a low blood urea nitrogen. The classic exam contrast is hereditary orotic aciduria, which also raises orotic acid but presents with megaloblastic anemia and normal ammonia.
Severe defects typically present in the first days of life once protein feeding begins, with poor feeding, vomiting, lethargy, and tachypnea. The hyperventilation drives a respiratory alkalosis, a finding that distinguishes these disorders from organic acidemias with metabolic acidosis. Untreated hyperammonemia progresses to cerebral edema, seizures, and coma. Partial deficiencies, particularly in heterozygous females with OTC deficiency, may not declare themselves until a later catabolic stress such as illness, fasting, or a high-protein load.
Ammonia damages the central nervous system in part by consuming α-ketoglutarate as it is fixed into glutamate and glutamine, depleting a key TCA cycle intermediate and impairing cerebral energy production. Standard management principles center on limiting nitrogen intake and using nitrogen-scavenging agents such as benzoate and phenylbutyrate, which route nitrogen into excretable conjugates that bypass the blocked cycle.
USMLE Step 1 tests this material heavily in biochemistry. High-yield points are the enzyme order of the cycle, OTC deficiency as the X-linked exception, the orotic acid plus hyperammonemia pattern and its contrast with hereditary orotic aciduria, and the respiratory alkalosis seen in a hyperammonemic neonate.
Key takeaways
- Urea cycle disorders block the conversion of ammonia to urea, producing hyperammonemia.
- Ornithine transcarbamylase deficiency is the most common and the only X-linked urea cycle disorder.
- OTC deficiency raises orotic acid with hyperammonemia and low BUN; hereditary orotic aciduria raises orotic acid with megaloblastic anemia and normal ammonia.
- Severe forms present in the neonatal period with lethargy, vomiting, and a respiratory alkalosis from hyperventilation.
- Ammonia toxicity depletes α-ketoglutarate, impairing the TCA cycle in the brain.
